Диссертация (1140954), страница 12
Текст из файла (страница 12)
Morandi, I.Prigione, V. Pistoia. // Cancer Immunol. Immunother. – 2008. – V. 57(4). – P.541–548.8.Akashi T. Chemokine receptor CXCR4 expression and prognosis in patients withmetastatic prostate cancer / T. Akashi, K. Koizumi, K. Tsuneyama, I. Saiki, Y.Takano, H. Fuse // Cancer Sci. – 2008. – V. 99(3). – P. 539–542.9.Amersi F.F. Activation of CCR9/CCL25 in cutaneous melanoma mediatespreferential metastasis to the small intestine / F.F. Amersi, A.M. Terando, Y.Goto, R.A. Scolyer, J.F.
Thompson, A.N. Tran, M.B. Faries, D.L. Morton, D.S.Hoon // Clin. Cancer Res. – 2008. – V. 14(3). – P. 638–645.8210.Andersson A. IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivityin lung cancer / A. Andersson, S-C. Yang, M. Huang, L. Zhu, U.K. Kar, R.K.Batra et al. // J Immunol. – 2009. – V. 182. – P. 6951–6958.11.Ansel K.M. A chemokine-driven positive feedback loop organizes lymphoidfollicles / K.M. Ansel, V.N. Ngo, P.L. Hyman, S.A. Luther, R.
Forster, J.D.Sedgwick, J.L. Browning, M. Lipp, J.G. Cyster // Nature. – 2000. – V. 406(6793).– P. 309–31412.Apte R.N. Is interleukin-1 a good or bad ‘guy’ in tumor immunobiology andimmunotherapy? / R.N. Apte, E. Voronov / Immunol Rev. – 2008. – V. 222. – P.222–241.13.Arigami T. CCR7 and CXCR4 expression predicts lymph node status includingmicrometastasis in gastric cancer / T. Arigami, S.
Natsugoe, Y. Uenosono, S.Yanagita, H. Arima, M. Hirata, S. Ishigami, T.Aikou // Int. J. Oncol. – 2009. – V.35(1). – P. 19–24.14.Baines J. Immune-mediated tumor regression induced by CpG-containingoligodeoxynucleotides / J. Baines, E. Celis // Clinical cancer research: an officialjournal of the American Association for Cancer Research. – 2003. – V. 9. – P.2693–2700.15.Ballas Z.K.
Induction of NK activity in murine and human cells by CpG motifs inoligodeoxynucleotides and bacterial DNA / Z.K. Ballas, W.L. Rasmussen, A.M.Krieg // J Immunol. – 1996. – V. 157. – P. 1840–1845.16.Balkwill F. Tumour necrosis factor and cancer / F. Balkwill // Nat Rev Cancer. –2009. – V. 9. – P. 361–371.17.Bauer A.K. Toll-like receptor 4 in butylated hydroxytoluene-induced mousepulmonary inflammation and tumorigenesis / A.K.
Bauer et al. // Journal of theNational Cancer Institute. – 2005. – V. 97. – P. 1778–1781.8318.Biswas S.K. Macrophage plasticity and interaction with lymphocyte subsets:cancer as a paradigm / S.K. Biswas, A. Mantovani // Nat Immunol. – 2010. – V.11. – P. 889–896.19.Bender G.N. Malignant melanoma: patterns of metastasis to the small bowel,reliability of imaging studies, and clinical relevance / G.N. Bender, D.D.Maglinte, J.H. McLarney, D. Rex, F.M.
Kelvin // Am. J. Gastroenterol. – 2001. –V. 96(8). – P. 2392–2400.20.Blecker D. Melanoma in the gastrointestinal tract / D. Blecker, S. Abraham, E.E.Furth, M.L. Kochman // Am. J. Gastroenterol. – 1999. – V. 94(12). – P. 3427–3433.21.Bolitho C. The chemokine CXCL1 induces proliferation in epithelial ovariancancer cells by transactivation of the epidermal growth factor receptor / C.Bolitho, M.A. Hahn, R.C. Baxter, D.J. Marsh // Endocr Relat Cancer. – 2010. –V. 17(4). – P.
929-940.22.Bos P.D. Transient regulatory T cell ablation deters oncogene-driven breastcancer and enhances radiotherapy / P.D. Bos, G. Plitas, D. Rudra, S.Y. Lee, A.Y.Rudensky // J Exp Med. – 2013. – V. 210. – P. 2435-2466.23.Brignole C. Therapeutic targeting of TLR9 inhibits cell growth and inducesapoptosis in neuroblastoma / C.
Brignole et al. // Cancer research. – 2010. – V.70. – P. 9816–9826.24.Bruce J. Patterns of recurrent disease in breast cancer / J. Bruce, D.C. Carter, J.Fraser // Lancet. – 1970. – V. 1(7644). – P. 433–435.25.Bruns P. Die Heilwirkung des Erysipelas auf Geschwülste / P. Bruns // Beitr KlinChir. – 1888. – V. 3. – P. 443.26.Buonamici S. CCR7 signalling as an essential regulator of CNS infiltration in Tcell leukaemia / S. Buonamici, T. Trimarchi, M.G. Ruocco, L. Reavie, S. Cathelinet al. // Nature. – 2009. – V. 459(7249).
– P. 1000–1004.27.Cabioglu N. CCR7 and CXCR4 as novel biomarkers predicting axillary lymphnode metastasis in T1 breast cancer / N. Cabioglu, M.S. Yazici, B. Arun, K.R.84Broglio, G.N. Hortobagyi, J.E. Price, A. Sahin // Clin. Cancer Res. – 2005. – V.11(16). – P. 5686–5693.28.Cai Z. Activation of Toll-like receptor 5 on breast cancer cells by flagellinsuppresses cell proliferation and tumor growth / Z. Cai et al. // Cancer research. –2011. – V. 71. – P.
2466–2475.29.Cambien B. Organ-specific inhibition of metastatic colon carcinoma by CXCR3antagonism / B. Cambien, B.F. Karimdjee, P. Richard-Fiardo, H. Bziouech, R.Barthel et al. // Br. J. Cancer. – 2009. – V. 100(11). – P. 1755–1764.30.Campanella G.S. CXCL10 can inhibit endothelial cell proliferation independentlyof CXCR3 / G.S. Campanella, R.A. Colvin, A.D. Luster // PLoS One. – 2010. –V. 5.
– P. e12700.31.Carpentier A. Oligodeoxynucleotides containing CpG motifs can induce rejectionof a neuroblastoma in mice / A. Carpentier, L. Chen, F. Maltonti, J. Delattre //Cancer research. – 1999. – V. 59. – P. 5429–5432.32.Cataisson C. IL-1R-MyD88 signaling in keratinocyte transformation andcarcinogenesis / C. Cataisson et al. // The Journal of experimental medicine. –2012. – V. 209. – P. 1689–1702.33.Chen H.J. Chemokine 25-induced signaling suppresses colon cancer invasion andmetastasis / H.J. Chen, R. Edwards, S. Tucci, P.
Bu, J. Milsom, S. Lee, W.Edelmann, Z.H. Gümüs, X. Shen, S.J. Lipkin // Clin Invest. – 2012. – V. 122(9).– P. 3184-3196.34.Cherfils-Vicini J. Triggering of TLR7 and TLR8 expressed by human lung cancercells induces cell survival and chemoresistance / J. Cherfils-Vicini et al.
// TheJournal of clinical investigation. – 2010. – V. 120. – P. 1285–1297.35.Chin A.I. Toll-like receptor 3-mediated suppression of TRAMP prostate cancershows the critical role of type I interferons in tumor immune surveillance / A.I.Chin et al. // Cancer research. – 2010. – V.
70. – P. 2595–2603.8536.Chew V. Toll-like receptor 3 expressing tumor parenchyma and infiltratingnatural killer cells in hepatocellular carcinoma patients / V. Chew et al. // Journalof the National Cancer Institute. – 2012.
– V. 104. – P. 1796–1807.37.Coley W.B. Treatment of inoperable malignant tumors with the toxins oferysipelas and the Bacillus prodigiosus / W.B. Coley // Trans Amer Surg Assn. –1894. – V. 12. – P. 183–212.38.Comerford I. Advances in understanding the pathogenesis of autoimmunedisorders: focus on chemokines and lymphocyte trafficking / I. Comerford, E.E.Kara, D.R. Mckenzie, S.R. Mccoll // Br. J. Haematol.
– 2014. – V. 164. – P. 329–341.39.Coussens L.M. Neutralizing tumor-promoting chronic inflammation: a magicbullet? / L.M. Coussens, L. Zitvogel, A.K. Palucka // Science. – 2013. – V. 339. –P. 286–291.40.Cunningham H.D. Expression of the C-C chemokine receptor 7 mediatesmetastasis of breast cancer to the lymph nodes in mice / H.D. Cunningham, L.A.Shannon, P.A. Calloway, B.C. Fassold, I. Dunwiddie, G. Vielhauer, M. Zhang,C.M.
Vines // Transl Oncol. – 2010. – V. 3(6). – P. 354–361.41.Curiel T.J. Specific recruitment of regulatory T cells in ovarian carcinoma fostersimmune privilege and predicts reduced survival / T.J. Curiel, G. Coukos, L. Zou,X. Alvarez, P. Cheng, P. Mottram et al. // Nat Med. – 2004. – V. 10. – P. 942–949.42.Dajon, M., Iribarren, K., & Cremer, I. (2017). Toll-like receptor stimulation incancer: A pro- and anti-tumor double-edged sword. Immunobiology, 222(1), 89–100.43.Dapito D.H.
Promotion of hepatocellular carcinoma by the intestinal microbiotaand TLR4 / D.H. Dapito et al. // Cancer Cell. – 2012. – V. 21. – P. 504–516.44.Darash-Yahana M. Role of high expression levels of CXCR4 in tumor growth,vascularization, and metastasis / M. Darash-Yahana, E. Pikarsky, R.86Abramovitch, E. Zeira, B. Pal, R. Karplus et al. // FASEB J. – 2004. – V.
18. – P.1240–1242.45.Das S. Tumor cell entry into the lymph node is controlled by CCL1 chemokineexpressed by lymph node lymphatic sinuses / S. Das, E. Sarrou, S. Podgrabinska,M. Cassella, S.K. Mungamuri, N. Feirt et al. // J Exp Med. – 2013. – V. 210. – P.1509–1528.46.Dimberg A. The Chemokine System in Experimental and Clinical Hematology /A. Dimberg // Springer; 2010. Chemokines in angiogenesis; pp. 59–80. .47.Ding Y.
Association of CC chemokine receptor 7 with lymph node metastasis ofesophageal squamous cell carcinoma / Y. Ding, Y. Shimada, M. Maeda, A.Kawabe, J. Kaganoi et al. // Clin. Cancer Res. – 2003. – V. 9(9). – P. 3406–3412.48.Droemann D. Human lung cancer cells express functionally active Toll-likereceptor 9 / D. Droemann et al. // Respiratory research. – 2005. – V. 6.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
